Search

Displaying results 5641 - 5650 of 7604 in total

Drug
Liranaftate
go.drugbank.com/drugs/DB19985
Experimental
Liranaftate is a small molecule drug. Liranaftate has a monoisotopic molecular weight of 328.12 Da.
Categories: Antifungals for Topical Use, Antifungals for Dermatological Use
Drug
Dovitinib
go.drugbank.com/drugs/DB05928
Investigational
Chiron currently has three ongoing Phase I clinical trials for dovitinib.
Drug
MLN0415
go.drugbank.com/drugs/DB05183
Experimental
Because inflammatory proteins play a critical role in inflammation and drive the inflammatory response to disease, controlling these proteins may prevent or slow disease progression.
Drug
Ferric subsulfate
go.drugbank.com/drugs/DB13885
Approved
Ferric subsulfate is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. It has the chemical formula Fe4(OH)2(SO4)5.
Drug
RGX-111
go.drugbank.com/drugs/DB17632
Investigational
Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]
Drug
SM-1997
go.drugbank.com/drugs/DB18670
Experimental
[A261816] It is under investigation for the treatment of cutaneous sulfur mustard-induced injury.
Drug
Tulisokibart
go.drugbank.com/drugs/DB18719
Investigational
It is being investigated for ulcerative colitis.
Drug
Beta-D-Glucose
go.drugbank.com/drugs/DB02379
Investigational
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state.
Drug
Metribolone
go.drugbank.com/drugs/DB02998
Experimental
It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.
Drug
Azelnidipine
go.drugbank.com/drugs/DB09230
Investigational
It is currently being studied for post-ischemic stroke management [L1380].